TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Test and Treat TB: A Proof of Concept Trial in South Africa
Brief Summary: The purpose of this study is (1) to establish the feasibility, yield, and clinical impact of a "Test \& Treat TB" strategy on a mobile HIV screening unit in South Africa and (2) to assess the cost and cost-effectiveness of this mobile, integrated HIV/TB screening strategy for maximizing linkage to TB care and treatment completion.


Options:
A: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Test-and-Treat Intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Test-and-Treat TB | Intervention Type: OTHER; Name: Test-and-Treat TB; Assigned to Arm(s): Test-and-Treat Intervention
B: Arm Label: Novel; Type: EXPERIMENTAL; Interventions: Procedure: GeneXpert MTB/RIF assay, Procedure: Smear microscopy | Arm Label: Standard; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Smear microscopy | Intervention Type: PROCEDURE; Name: GeneXpert MTB/RIF assay; Assigned to Arm(s): Novel | Intervention Type: PROCEDURE; Name: Smear microscopy; Assigned to Arm(s): Novel, Standard
C: Intervention Type: OTHER; Name: No Intervention; Assigned to Arm(s): N/A
D: Arm Label: Antiretroviral therapy, tuberculosis; Type: N/A; Interventions: N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II, Open-label, Multicentre, Randomised Study of the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of CAM2029 in Patients With Acromegaly and Neuroendocrine Tumours (NETs) Previously Treated With Sandostatin® LAR®
Brief Summary: This is a Phase II, open-label multicentre, randomised study to assess the PK, PD, efficacy, and safety of two dosing regimens of CAM2029 in adult patients with acromegaly or a functional, well-differentiated NET, with carcinoid symptoms.


Options:
A: Arm Label: octreotide; Type: EXPERIMENTAL; Interventions: Drug: Octreotide | Arm Label: standard surgery; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Direct surgery for acromegaly | Intervention Type: DRUG; Name: Octreotide; Assigned to Arm(s): octreotide | Intervention Type: PROCEDURE; Name: Direct surgery for acromegaly; Assigned to Arm(s): standard surgery
B: Arm Label: Pasireotide LAR; Type: EXPERIMENTAL; Interventions: Drug: Pasireotide LAR | Intervention Type: DRUG; Name: Pasireotide LAR; Assigned to Arm(s): Pasireotide LAR
C: Arm Label: Octreotide 30 mg every 21 days; Type: EXPERIMENTAL; Interventions: Drug: Octreotide acetate 30 mg suspension | Arm Label: Octreotide 60 mg every 28 days; Type: EXPERIMENTAL; Interventions: Drug: Octreotide acetate 30 mg suspension | Intervention Type: DRUG; Name: Octreotide acetate 30 mg suspension; Assigned to Arm(s): Octreotide 30 mg every 21 days, Octreotide 60 mg every 28 days
D: Arm Label: CAM2029 10 mg (NET); Type: EXPERIMENTAL; Interventions: Drug: octreotide FluidCrystal® injection depot | Arm Label: CAM2029 20 mg (NET); Type: EXPERIMENTAL; Interventions: Drug: octreotide FluidCrystal® injection depot | Arm Label: CAM2029 10 mg (Acromegaly); Type: EXPERIMENTAL; Interventions: Drug: octreotide FluidCrystal® injection depot | Arm Label: CAM2029 20 mg (Acromegaly); Type: EXPERIMENTAL; Interventions: Drug: octreotide FluidCrystal® injection depot | Intervention Type: DRUG; Name: octreotide FluidCrystal® injection depot; Assigned to Arm(s): CAM2029 10 mg (Acromegaly), CAM2029 10 mg (NET), CAM2029 20 mg (Acromegaly), CAM2029 20 mg (NET)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of Advance Care Planning on Care for Patients With Advanced Heart Failure: A Randomized Controlled Trial
Brief Summary: Aims: Advance care planning (ACP) is considered to be one of the most promising interventions to enable patients with life limiting illnesses to receive treatment at the end of life (EOL) according to their own preferences and to promote EOL conversations between patients and their health care providers. Through a 2-arm randomized controlled trial (RCT) of patients with Class III and IV heart failure (New York Heart Association Functional Classification), we propose to assess:

1. Whether patients in the ACP arm have a greater likelihood of receiving EOL care consistent with their preferences as stated in the latter of the last ACP document or the last patient interview, compared to patients in the control arm.
2. Heath care costs during study duration between patients in ACP and control arms.
3. Patient's understanding of own illness and their participation in decision making between the ACP and control arms.
4. Patient's quality of life, anxiety and depression between ACP and control arms.

Methodology: A total of 254 patients with advance heart failure will be randomized to receive intervention (ACP arm; N=127) or usual care (control arm; N=127).

The RCT will be conducted at the National Heart Centre and Singapore General Hospital. Patients in both arms will be followed for one year or till death, whichever is earlier, and interviewed every 4 months during this duration.

Clinical Significance: If benefits of ACP are shown to add value through this trial, then this study will help to promote acceptance of ACP among patients and health care providers across Singapore and elsewhere.


Options:
A: Arm Label: Integrated care; Type: EXPERIMENTAL; Interventions: Other: Integrated care | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Integrated care; Assigned to Arm(s): Integrated care | Intervention Type: OTHER; Name: Integrated care; Assigned to Arm(s): Integrated care
B: Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention (ACP) arm; Type: EXPERIMENTAL; Interventions: Behavioral: ACP | Intervention Type: BEHAVIORAL; Name: ACP; Assigned to Arm(s): Intervention (ACP) arm
C: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Control | Arm Label: Verbal Information and Discussion; Type: EXPERIMENTAL; Interventions: Other: Verbal Information and Discussion | Intervention Type: OTHER; Name: Verbal Information and Discussion; Assigned to Arm(s): Verbal Information and Discussion | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
D: Arm Label: Intervention: ACP conversation; Type: EXPERIMENTAL; Interventions: Behavioral: ACp conversation | Arm Label: No intervention: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ACp conversation; Assigned to Arm(s): Intervention: ACP conversation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Assessing the Effectiveness of Two Regimens of Misoprostol Alone for Early Pregnancy Termination and Use of a Semi-Quantitative Pregnancy Test for At-Home Follow-Up
Brief Summary: This randomized trial will compare the rates of ongoing pregnancy, safety/side effects and acceptability of two medical abortion regimens that are commonly used in Latin America. The first regimen will involve three 800 mcg doses of misoprostol taken buccally in three hour intervals; the second will involve three 800 mcg doses of misoprostol taken sublingually in three hour intervals. This study will also aim to assess the feasibility and acceptability of a semi-quantitative pregnancy test (SQPT) for at-home follow-up in both settings.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: MIFEPRISTONE 200 mg and misoprostol 400 µg | Intervention Type: DRUG; Name: MIFEPRISTONE 200 mg and misoprostol 400 µg; Assigned to Arm(s): 1
B: Arm Label: 64-70 days' gestational age; Type: EXPERIMENTAL; Interventions: Drug: Mifepristone and misoprostol | Arm Label: 57-63 days' gestational age; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Mifepristone and misoprostol; Assigned to Arm(s): 64-70 days' gestational age
C: Arm Label: Buccal; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol, Device: Semi-quantitative pregnancy test | Arm Label: Sublingual; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol, Device: Semi-quantitative pregnancy test | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Buccal, Sublingual | Intervention Type: DEVICE; Name: Semi-quantitative pregnancy test; Assigned to Arm(s): Buccal, Sublingual
D: Intervention Type: DRUG; Name: mifepristone and misoprostol; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of the Effects of Ketamine in the Acute Phase of Suicidal Ideation: a Multicenter Randomized Double-blind Trial
Brief Summary: The primary objective of this study is to assess the efficacy of ketamine versus a placebo for the short-term (at 72h, i.e. 24h after the last perfusion) relief of suicidal ideation, measured using the BSS hetero questionnaire, in patients hospitalized for suicide risk.


Options:
A: Intervention Type: BEHAVIORAL; Name: Cognitive Therapy; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Supportive Therapy; Assigned to Arm(s): N/A
B: Arm Label: Cognitive Therapy; Type: OTHER; Interventions: Behavioral: Cognitive Therapy | Arm Label: Enriched Care; Type: OTHER; Interventions: Other: Enriched Care | Intervention Type: BEHAVIORAL; Name: Cognitive Therapy; Assigned to Arm(s): Cognitive Therapy | Intervention Type: OTHER; Name: Enriched Care; Assigned to Arm(s): Enriched Care
C: Arm Label: active anodal tDCS to ventrolateral prefrontal cortex (VLPFC); Type: ACTIVE_COMPARATOR; Interventions: Device: Transcranial direct current stimulation | Arm Label: sham anodal tDCS to VLPFC; Type: SHAM_COMPARATOR; Interventions: Device: Transcranial direct current stimulation | Arm Label: Discontinued prior to randomization; Type: OTHER; Interventions: Other: No intervention | Intervention Type: DEVICE; Name: Transcranial direct current stimulation; Assigned to Arm(s): active anodal tDCS to ventrolateral prefrontal cortex (VLPFC), sham anodal tDCS to VLPFC | Intervention Type: OTHER; Name: No intervention; Assigned to Arm(s): Discontinued prior to randomization
D: Arm Label: Ketamine; Type: EXPERIMENTAL; Interventions: Other: Baseline evaluation, Drug: 1st perfusion of ketamine, Other: Follow-up between perfusions, Drug: 2nd perfusion of ketamine | Arm Label: Placebo/Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Baseline evaluation, Drug: 1st perfusion of saline, Other: Follow-up between perfusions, Drug: 2nd perfusion of saline | Intervention Type: OTHER; Name: Baseline evaluation; Assigned to Arm(s): Ketamine, Placebo/Control | Intervention Type: DRUG; Name: 1st perfusion of ketamine; Assigned to Arm(s): Ketamine | Intervention Type: DRUG; Name: 1st perfusion of saline; Assigned to Arm(s): Placebo/Control | Intervention Type: OTHER; Name: Follow-up between perfusions; Assigned to Arm(s): Ketamine, Placebo/Control | Intervention Type: DRUG; Name: 2nd perfusion of ketamine; Assigned to Arm(s): Ketamine | Intervention Type: DRUG; Name: 2nd perfusion of saline; Assigned to Arm(s): Placebo/Control

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of the Effects of Ketamine in the Acute Phase of Suicidal Ideation: a Multicenter Randomized Double-blind Trial
Brief Summary: The primary objective of this study is to assess the efficacy of ketamine versus a placebo for the short-term (at 72h, i.e. 24h after the last perfusion) relief of suicidal ideation, measured using the BSS hetero questionnaire, in patients hospitalized for suicide risk.


Options:
A: Arm Label: Culturally adapted therapy (C-MAP); Type: EXPERIMENTAL; Interventions: Behavioral: Culturally adapted therapy (C-MAP) | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Culturally adapted therapy (C-MAP); Assigned to Arm(s): Culturally adapted therapy (C-MAP)
B: Arm Label: Ketamine; Type: EXPERIMENTAL; Interventions: Other: Baseline evaluation, Drug: 1st perfusion of ketamine, Other: Follow-up between perfusions, Drug: 2nd perfusion of ketamine | Arm Label: Placebo/Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Baseline evaluation, Drug: 1st perfusion of saline, Other: Follow-up between perfusions, Drug: 2nd perfusion of saline | Intervention Type: OTHER; Name: Baseline evaluation; Assigned to Arm(s): Ketamine, Placebo/Control | Intervention Type: DRUG; Name: 1st perfusion of ketamine; Assigned to Arm(s): Ketamine | Intervention Type: DRUG; Name: 1st perfusion of saline; Assigned to Arm(s): Placebo/Control | Intervention Type: OTHER; Name: Follow-up between perfusions; Assigned to Arm(s): Ketamine, Placebo/Control | Intervention Type: DRUG; Name: 2nd perfusion of ketamine; Assigned to Arm(s): Ketamine | Intervention Type: DRUG; Name: 2nd perfusion of saline; Assigned to Arm(s): Placebo/Control
C: Arm Label: Post Admission Cognitive Therapy (PACT); Type: EXPERIMENTAL; Interventions: Behavioral: Post Admission Cognitive Therapy (PACT) | Arm Label: Enhanced Usual Care (EUC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Post Admission Cognitive Therapy (PACT); Assigned to Arm(s): Post Admission Cognitive Therapy (PACT)
D: Arm Label: Family-Enhanced Non-directive Supportive Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Family-Enhanced Non-directive Supportive Therapy | Arm Label: Attachment-Based Family Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Attachment-Based Family Therapy | Intervention Type: BEHAVIORAL; Name: Attachment-Based Family Therapy; Assigned to Arm(s): Attachment-Based Family Therapy | Intervention Type: BEHAVIORAL; Name: Family-Enhanced Non-directive Supportive Therapy; Assigned to Arm(s): Family-Enhanced Non-directive Supportive Therapy

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of the Effects of Ketamine in the Acute Phase of Suicidal Ideation: a Multicenter Randomized Double-blind Trial
Brief Summary: The primary objective of this study is to assess the efficacy of ketamine versus a placebo for the short-term (at 72h, i.e. 24h after the last perfusion) relief of suicidal ideation, measured using the BSS hetero questionnaire, in patients hospitalized for suicide risk.


Options:
A: Arm Label: Ketamine; Type: EXPERIMENTAL; Interventions: Other: Baseline evaluation, Drug: 1st perfusion of ketamine, Other: Follow-up between perfusions, Drug: 2nd perfusion of ketamine | Arm Label: Placebo/Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Baseline evaluation, Drug: 1st perfusion of saline, Other: Follow-up between perfusions, Drug: 2nd perfusion of saline | Intervention Type: OTHER; Name: Baseline evaluation; Assigned to Arm(s): Ketamine, Placebo/Control | Intervention Type: DRUG; Name: 1st perfusion of ketamine; Assigned to Arm(s): Ketamine | Intervention Type: DRUG; Name: 1st perfusion of saline; Assigned to Arm(s): Placebo/Control | Intervention Type: OTHER; Name: Follow-up between perfusions; Assigned to Arm(s): Ketamine, Placebo/Control | Intervention Type: DRUG; Name: 2nd perfusion of ketamine; Assigned to Arm(s): Ketamine | Intervention Type: DRUG; Name: 2nd perfusion of saline; Assigned to Arm(s): Placebo/Control
B: Arm Label: Psychoeducational intervention (PEI); Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducational intervention (PEI) | Arm Label: Enhanced Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced treatment as usual (ETAU) | Intervention Type: BEHAVIORAL; Name: Psychoeducational intervention (PEI); Assigned to Arm(s): Psychoeducational intervention (PEI) | Intervention Type: BEHAVIORAL; Name: Enhanced treatment as usual (ETAU); Assigned to Arm(s): Enhanced Treatment as Usual
C: Arm Label: Control group; Type: OTHER; Interventions: Behavioral: Relaxation | Arm Label: Therapy ACT; Type: EXPERIMENTAL; Interventions: Behavioral: ACT therapy | Intervention Type: BEHAVIORAL; Name: Relaxation; Assigned to Arm(s): Control group | Intervention Type: BEHAVIORAL; Name: ACT therapy; Assigned to Arm(s): Therapy ACT
D: Arm Label: Compassion meditation (CM); Type: EXPERIMENTAL; Interventions: Behavioral: Compassion meditation (CM) | Arm Label: Support group (SG); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Support group (SG) | Intervention Type: BEHAVIORAL; Name: Compassion meditation (CM); Assigned to Arm(s): Compassion meditation (CM) | Intervention Type: BEHAVIORAL; Name: Support group (SG); Assigned to Arm(s): Support group (SG)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: This study investigates the effect of varying both energy density and portion size of all foods at lunch on preschool children's intake. The foods used in this study are commercially-available, commonly-consumed foods with typical variations in energy density. The primary aim of the study is to investigate the independent and combined effects of energy density and portion size on preschool children's intake at a meal composed of foods typically served to this population.


Options:
A: Arm Label: AA - Increase vegetable intake; Type: EXPERIMENTAL; Interventions: Behavioral: Increase vegetable intake in pre-school children | Arm Label: HA - Increase vegetable intake; Type: EXPERIMENTAL; Interventions: Behavioral: Increase vegetable intake in pre-school children | Intervention Type: BEHAVIORAL; Name: Increase vegetable intake in pre-school children; Assigned to Arm(s): AA - Increase vegetable intake, HA - Increase vegetable intake
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: KAN-DO | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: KAN-DO | Intervention Type: BEHAVIORAL; Name: KAN-DO; Assigned to Arm(s): 1, 2
C: Arm Label: Low Energy Density, Small Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: Low Energy Density, Medium Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: Low Energy Density, Large Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: High Energy Density, Small Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: High Energy Density, Medium Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: High Energy Density, Large Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Intervention Type: OTHER; Name: Varying meal energy density and portion size; Assigned to Arm(s): High Energy Density, Large Portions, High Energy Density, Medium Portions, High Energy Density, Small Portions, Low Energy Density, Large Portions, Low Energy Density, Medium Portions, Low Energy Density, Small Portions
D: Arm Label: NOURISH-T; Type: EXPERIMENTAL; Interventions: Behavioral: NOURISH-T | Arm Label: Enhanced Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Usual Care | Intervention Type: BEHAVIORAL; Name: NOURISH-T; Assigned to Arm(s): NOURISH-T | Intervention Type: BEHAVIORAL; Name: Enhanced Usual Care; Assigned to Arm(s): Enhanced Usual Care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: This study investigates the effect of varying both energy density and portion size of all foods at lunch on preschool children's intake. The foods used in this study are commercially-available, commonly-consumed foods with typical variations in energy density. The primary aim of the study is to investigate the independent and combined effects of energy density and portion size on preschool children's intake at a meal composed of foods typically served to this population.


Options:
A: Arm Label: HOME Plus Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: HOME Plus intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: HOME Plus intervention; Assigned to Arm(s): HOME Plus Intervention
B: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Behavioral: Education, Behavioral: Problem Solving, Behavioral: Social Learning, Behavioral: Behavior Modification | Arm Label: Group B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Group A, Group B | Intervention Type: BEHAVIORAL; Name: Problem Solving; Assigned to Arm(s): Group A | Intervention Type: BEHAVIORAL; Name: Social Learning; Assigned to Arm(s): Group A | Intervention Type: BEHAVIORAL; Name: Behavior Modification; Assigned to Arm(s): Group A
C: Arm Label: Low Energy Density, Small Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: Low Energy Density, Medium Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: Low Energy Density, Large Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: High Energy Density, Small Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: High Energy Density, Medium Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: High Energy Density, Large Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Intervention Type: OTHER; Name: Varying meal energy density and portion size; Assigned to Arm(s): High Energy Density, Large Portions, High Energy Density, Medium Portions, High Energy Density, Small Portions, Low Energy Density, Large Portions, Low Energy Density, Medium Portions, Low Energy Density, Small Portions
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary Advice | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary Advice; Assigned to Arm(s): Intervention

Answer: C